This AOP is licensed under the BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.

AOP: 564

Title

A descriptive phrase which references both the Molecular Initiating Event and Adverse Outcome.It should take the form “MIE leading to AO”. For example, “Aromatase inhibition leading to reproductive dysfunction” where Aromatase inhibition is the MIE and reproductive dysfunction the AO. In cases where the MIE is unknown or undefined, the earliest known KE in the chain (i.e., furthest upstream) should be used in lieu of the MIE and it should be made clear that the stated event is a KE and not the MIE.  More help

DBDPE-induced inhibition of mitochondrial complex Ⅰ leading to population decline via neurotoxicity and metabotoxicity.

Short name
A name that succinctly summarises the information from the title. This name should not exceed 90 characters. More help
DBDPE inhibits mitochondria leading to population decline
The current version of the Developer's Handbook will be automatically populated into the Handbook Version field when a new AOP page is created.Authors have the option to switch to a newer (but not older) Handbook version any time thereafter. More help
Handbook Version v2.7

Graphical Representation

A graphical representation of the AOP.This graphic should list all KEs in sequence, including the MIE (if known) and AO, and the pair-wise relationships (links or KERs) between those KEs. More help
Click to download graphical representation template Explore AOP in a Third Party Tool

Authors

The names and affiliations of the individual(s)/organisation(s) that created/developed the AOP. More help

Lihua Yang, Biran Zhu, Yumiao Sun, Tao Xu, Jian Han and Bingsheng Zhou

Point of Contact

The user responsible for managing the AOP entry in the AOP-KB and controlling write access to the page by defining the contributors as described in the next section.   More help
lihua Yang   (email point of contact)

Contributors

Users with write access to the AOP page.  Entries in this field are controlled by the Point of Contact. More help
  • lihua Yang

Coaches

This field is used to identify coaches who supported the development of the AOP.Each coach selected must be a registered author. More help

OECD Information Table

Provides users with information concerning how actively the AOP page is being developed and whether it is part of the OECD Workplan and has been reviewed and/or endorsed. OECD Project: Assigned upon acceptance onto OECD workplan. This project ID is managed and updated (if needed) by the OECD. OECD Status: For AOPs included on the OECD workplan, ‘OECD status’ tracks the level of review/endorsement of the AOP . This designation is managed and updated by the OECD. Journal-format Article: The OECD is developing co-operation with Scientific Journals for the review and publication of AOPs, via the signature of a Memorandum of Understanding. When the scientific review of an AOP is conducted by these Journals, the journal review panel will review the content of the Wiki. In addition, the Journal may ask the AOP authors to develop a separate manuscript (i.e. Journal Format Article) using a format determined by the Journal for Journal publication. In that case, the journal review panel will be required to review both the Wiki content and the Journal Format Article. The Journal will publish the AOP reviewed through the Journal Format Article. OECD iLibrary published version: OECD iLibrary is the online library of the OECD. The version of the AOP that is published there has been endorsed by the OECD. The purpose of publication on iLibrary is to provide a stable version over time, i.e. the version which has been reviewed and revised based on the outcome of the review. AOPs are viewed as living documents and may continue to evolve on the AOP-Wiki after their OECD endorsement and publication.   More help
OECD Project # OECD Status Reviewer's Reports Journal-format Article OECD iLibrary Published Version
This AOP was last modified on January 20, 2025 03:19

Revision dates for related pages

Page Revision Date/Time
Mitochondrial Complex I inhibition December 19, 2018 09:35
Altered, Redox Homeostasis January 20, 2025 03:20
Disruption, Mitochondrial electron transport chain September 16, 2017 10:14
Decrease, Mitochondrial ATP production September 16, 2017 10:14
Disruption, Glucolipid metabolism January 20, 2025 03:20
Disruption, neurotransmitter release July 21, 2023 16:35
Abnormal, Behavior January 20, 2025 03:21
impaired, Larval development December 03, 2016 16:37
Increase, Malformations January 20, 2025 03:27
Increased Mortality July 08, 2022 07:32
Decrease, Population growth rate January 03, 2023 09:09
Mitochondrial Complex I inhibition leads to Altered, Redox Homeostasis December 24, 2024 22:42
Altered, Redox Homeostasis leads to Disruption, Mitochondrial electron transport chain December 24, 2024 22:42
Disruption, Mitochondrial electron transport chain leads to Decrease, Mitochondrial ATP production December 03, 2016 16:37
Decrease, Mitochondrial ATP production leads to Disruption, Glucolipid metabolism December 24, 2024 22:42
Decrease, Mitochondrial ATP production leads to Disruption, neurotransmitter release December 24, 2024 22:43
Disruption, Glucolipid metabolism leads to impaired, Larval development December 24, 2024 22:43
Disruption, neurotransmitter release leads to Abnormal, Behavior December 24, 2024 22:44
Abnormal, Behavior leads to impaired, Larval development December 24, 2024 22:44
impaired, Larval development leads to Increase, Malformations December 24, 2024 22:44
Increase, Malformations leads to Increased Mortality December 24, 2024 22:45
Increased Mortality leads to Decrease, Population growth rate July 08, 2022 08:29
1,1'-Ethane-1,2-diylbis(pentabromobenzene) December 29, 2024 21:12

Abstract

A concise and informative summation of the AOP under development that can stand-alone from the AOP page. The aim is to capture the highlights of the AOP and its potential scientific and regulatory relevance. More help

The stressor DBDPE, used as a substitute for PBDEs, has widespread industrial applications. When zebrafish (Danio rerio) were cultured in water with high concentrations of DBDPE (100nM), multigenerational and transgenerational effects were observed in subsequent generations which increase malformation rate and decrease the survival rate. When nicotinamide riboside (NR) was added to the culture water, the adverse effects of DBDPE was alleviated (Yang et al., 2023). This intervention led us to determine that the disruption of regeneration of NAD+, which indicates the inhibition of mitochondria complex Ⅰ, serves as the molecular initiating event, triggering a series of downstream key events.

The molecular initiating event, inhibition of mitochondrial complex Ⅰ induces disruption of redox homeostasis, then disrupts the mitochondrial electron transport chain (Karamanlidis et al., 2013; Titov et al., 2016), leading to decreased ATP production(Vartak, Porras and Bai, 2013; Yang et al., 2023), following disrupts glucolipids metabolism (Gao et al., 2022; Vendemiale et al., 2001; Wang et al., 2014). Also, ATP production disrupts affecting neurotransmitter release(Harris, Jolivet and Attwell, 2012), resulting in the larvae behavior abnormality(Cavalcante et al., 2017; Ji et al., 2022; Yu et al., 2022). Finally, the impact of glucolipids metabolism and abnormal behavior in zebrafish larvae impairs larval development(Langer-Jaesrich, Kienle, Köhler and Gerhardt, 2010; Lu et al., 2019; Wu et al., 2021), then increasing the occurrence of malformations, which ultimately increasing mortality rates of larvae. The culmination of these effects is an overall decline in population growth rate, representing the adverse outcome of disruption of redox homeostasis.

AOP Development Strategy

Context

Used to provide background information for AOP reviewers and users that is considered helpful in understanding the biology underlying the AOP and the motivation for its development.The background should NOT provide an overview of the AOP, its KEs or KERs, which are captured in more detail below. More help

Decabromodiphenyl ethane (DBDPE) is a novel brominated flame retardant that is becoming increasingly prevalent in environmental and biota samples. As the molecular mechanism of its effects on living organisms remains unclear, this AOP is developed for its toxicity from the molecular level to the population level.

Strategy

Provides a description of the approaches to the identification, screening and quality assessment of the data relevant to identification of the key events and key event relationships included in the AOP or AOP network.This information is important as a basis to support the objective/envisaged application of the AOP by the regulatory community and to facilitate the reuse of its components.  Suggested content includes a rationale for and description of the scope and focus of the data search and identification strategy/ies including the nature of preliminary scoping and/or expert input, the overall literature screening strategy and more focused literature surveys to identify additional information (including e.g., key search terms, databases and time period searched, any tools used). More help

In this study, zebrafish embryos were exposed to DBDPE until 120 hours post fertilization (hpf) to assess its toxicity. Behavioral tests, neurotransmitter analysis, and transcriptome investigations on neurodevelopment-related genes revealed the neurotoxicity of DBDPE. Metabolomics analysis focusing on glycolipid metabolism, oxidative phosphorylation, and oxidative stress were conducted to validate metabolism alterations. The mitochondrial performance was evaluated by mitochondrial oxidative respiration tests including mitochondrial respiratory chain complex activities, mitochondrial membrane potential, and ATP contents, which demonstrated inhibited mitochondrial function. Furthermore, the addition of nicotinamide riboside was found to restore the impairments caused by DBDPE on mitochondria and neurons, indicating the molecular initiating event underlying its toxicity.

Summary of the AOP

This section is for information that describes the overall AOP.The information described in section 1 is entered on the upper portion of an AOP page within the AOP-Wiki. This is where some background information may be provided, the structure of the AOP is described, and the KEs and KERs are listed. More help

Events:

Molecular Initiating Events (MIE)
An MIE is a specialised KE that represents the beginning (point of interaction between a prototypical stressor and the biological system) of an AOP. More help
Key Events (KE)
A measurable event within a specific biological level of organisation. More help
Adverse Outcomes (AO)
An AO is a specialized KE that represents the end (an adverse outcome of regulatory significance) of an AOP. More help
Type Event ID Title Short name
MIE 1541 Mitochondrial Complex I inhibition Mitochondrial Complex I inhibition
KE 2299 Altered, Redox Homeostasis Altered, Redox Homeostasis
KE 178 Disruption, Mitochondrial electron transport chain Disruption, Mitochondrial electron transport chain
KE 40 Decrease, Mitochondrial ATP production Decrease, Mitochondrial ATP production
KE 2300 Disruption, Glucolipid metabolism Disruption, Glucolipid metabolism
KE 2151 Disruption, neurotransmitter release Disruption, neurotransmitter release
KE 2301 Abnormal, Behavior Abnormal, Behavior
AO 566 impaired, Larval development impaired, Larval development
AO 2302 Increase, Malformations Increase, Malformations
AO 351 Increased Mortality Increased Mortality
AO 360 Decrease, Population growth rate Decrease, Population growth rate

Relationships Between Two Key Events (Including MIEs and AOs)

This table summarizes all of the KERs of the AOP and is populated in the AOP-Wiki as KERs are added to the AOP.Each table entry acts as a link to the individual KER description page. More help

Network View

This network graphic is automatically generated based on the information provided in the MIE(s), KEs, AO(s), KERs and Weight of Evidence (WoE) summary tables. The width of the edges representing the KERs is determined by its WoE confidence level, with thicker lines representing higher degrees of confidence. This network view also shows which KEs are shared with other AOPs. More help

Prototypical Stressors

A structured data field that can be used to identify one or more “prototypical” stressors that act through this AOP. Prototypical stressors are stressors for which responses at multiple key events have been well documented. More help

Life Stage Applicability

The life stage for which the AOP is known to be applicable. More help
Life stage Evidence
Embryo High
Larvae High

Taxonomic Applicability

Latin or common names of a species or broader taxonomic grouping (e.g., class, order, family) can be selected.In many cases, individual species identified in these structured fields will be those for which the strongest evidence used in constructing the AOP was available. More help
Term Scientific Term Evidence Link
zebrafish Danio rerio High NCBI

Sex Applicability

The sex for which the AOP is known to be applicable. More help
Sex Evidence
Unspecific Not Specified

Overall Assessment of the AOP

Addressess the relevant biological domain of applicability (i.e., in terms of taxa, sex, life stage, etc.) and Weight of Evidence (WoE) for the overall AOP as a basis to consider appropriate regulatory application (e.g., priority setting, testing strategies or risk assessment). More help

This AOP is developed for zebrafish embryos exposed up to 120 hpf at the larval stage without a specific gender. It provides novel insight into the toxic mechanisms of DBDPE as well as other emerging pollutants.

Domain of Applicability

Addressess the relevant biological domain(s) of applicability in terms of sex, life-stage, taxa, and other aspects of biological context. More help

The research is conducted on zebrafish embryos up to 120 hpf, transitioning from the embryo to larval stage.

Essentiality of the Key Events

The essentiality of KEs can only be assessed relative to the impact of manipulation of a given KE (e.g., experimentally blocking or exacerbating the event) on the downstream sequence of KEs defined for the AOP. Consequently, evidence supporting essentiality is assembled on the AOP page, rather than on the independent KE pages that are meant to stand-alone as modular units without reference to other KEs in the sequence. The nature of experimental evidence that is relevant to assessing essentiality relates to the impact on downstream KEs and the AO if upstream KEs are prevented or modified. This includes: Direct evidence: directly measured experimental support that blocking or preventing a KE prevents or impacts downstream KEs in the pathway in the expected fashion. Indirect evidence: evidence that modulation or attenuation in the magnitude of impact on a specific KE (increased effect or decreased effect) is associated with corresponding changes (increases or decreases) in the magnitude or frequency of one or more downstream KEs. More help

When NR, which can rebalance redox homeostasis, is co-exposed with DBDPE, restores DBDPE-induced mitochondrial impairments and resultant neurotoxicity, oxidative stress as well as glycolipid metabolism in zebrafish larvae.

Evidence Assessment

Addressess the biological plausibility, empirical support, and quantitative understanding from each KER in an AOP. More help

KER 1: Inhibition of Mitochondrial Complex Ⅰ leads to Altered, Redox Homeostasis

The inhibition of mitochondrial complex will change the redox homeostasis which indicate the change of NAD+ /NADH ratio. In female nude mice, treated by metformin can inhibit the mitochondrial complex Ⅰ, which further decrease the ratio(Parisotto et al., 2022). Also, in mouse and mice hepatocytes, rotenone can inhibit the complex Ⅰ and reduce the NADH/NAD state(Alshawi and Agius, 2019). What’s more, the DBDPE inhibit the complex Ⅰ and alter the NAD+/NADH ratio in zebrafish larvae(Yang et al., 2023).

KER 2: Altered, Redox Homeostasis leads to Disruption, Mitochondrial electron transport chain

The change of NAD+/NADH ratio which also indicate the alteration of redox homeostasis, will disrupt the mitochondrial electron transport chain (ETC). In human, obesity will impair the ETC further decrease NAD+/NADH ratio which ultimately lead to accelerate heart failure (Karamanlidis et al., 2013). Also, in the human HeLa cells, when a gene LbNOX that inducing a compartment-specific increase of the NAD/NADH ratio is added to the mitochondria, the impact of doxycycline bring to the ETC is mitigated(Titov et al., 2016). In zebrafish larvae, the larvae impact by DBDPE have decrease in NAD+/NADH ratio and disrupted ETC, when nicotinamide riboside (NR) was added to the culture water, the adverse effects of DBDPE was alleviated(Yang et al., 2023).

KER3: Disruption, Mitochondrial electron transport chain leads to Decrease, Mitochondrial ATP production

Disruption of the mitochondrial electron transport chain impairs mitochondrial respiration, leading to decreased ATP production.

KER4: Decrease, Mitochondrial ATP production leads to Disruption, Glucolipid metabolism

The decrease of mitochondrial ATP contents or synthesis can disrupt glucolipid metabolism. In male SD rats, DBDPE can decrease ATP synthesis which induce disruption in glycolipid metabolism(Gao et al., 2022). Methionine and choline deficient diet in rats can induce nonalcoholic steatohepatitis and reduce ATP content result in dysregulated hepatic glycolipid metabolism(Vendemiale et al., 2001). Streptozotocin induced type 1 diabetic mice also reduced their ATP contents then make glycolipid metabolism dysregulated(Wang et al., 2014).

KER5: Disruption, Glucolipid metabolism leads to impaired, Larval development

The disruption in glycolipid metabolism can cause impaired in larval growth or development. In zebrafish larvae, procymidone can influence the lipid metabolism then cause developmental toxicity. Also, under co-exposure of neonicotinoid pesticide acetamiprid and cadmium will induce harmful effects on glycolipid metabolism which result in inhibitory effect on the growth of larvae. In silkworm, Overexpression of BmFoxO can induce disruption in glycolipid metabolism then affect growth.

KER6: Decrease, Mitochondrial ATP production leads to Disruption, Neurotransmitter release

Synapses are the primary sites of ATP consumption in the brain. The decrease in mitochondrial ATP production would likely impair neurotransmitter release at the synapse(Harris et al., 2012).

KER7: Disruption, Neurotransmitter release leads to Abnormal, Behavior

Disruption of neurotransmitter release will lead to behavior change. In zebrafish, 6PPD and zinc chloride both can altered neurotransmitter result in abnormal behavior, and DBDPE can elevate multiple neurotransmitters in larvae resulting in hyperactivity. What’s more, in rats, HIV antiretroviral drug Efavirenz can Altered neurotransmitters glutamate and GABA then lead to anxiety-like and depression-like behavior.

KER8: Abnormal, Behavior leads to impaired, Larval development

Abnormal behavior, such as impaired prey recognition caused by chlorpyrifos (CHP) exposure, can hinder larval feeding and ultimately impact their development(Langer-Jaesrich et al., 2010).

KER9: impaired, Larval development leads to Increase, Malformations

Impaired larval development may result in an increased incidence of malformations, as most of such malformations are linked to developmental failures.

KER10: Increase, Malformations leads to Increased Mortality

As the malformation in fish will impact its feeding and development, it’s reasonable to infer the increase of malformation will lead to increase in mortality.

Known Modulating Factors

Modulating factors (MFs) may alter the shape of the response-response function that describes the quantitative relationship between two KES, thus having an impact on the progression of the pathway or the severity of the AO.The evidence supporting the influence of various modulating factors is assembled within the individual KERs. More help
Modulating Factors(MF) impact or result involved KER
     

Quantitative Understanding

Optional field to provide quantitative weight of evidence descriptors.  More help

Considerations for Potential Applications of the AOP (optional)

Addressess potential applications of an AOP to support regulatory decision-making.This may include, for example, possible utility for test guideline development or refinement, development of integrated testing and assessment approaches, development of (Q)SARs / or chemical profilers to facilitate the grouping of chemicals for subsequent read-across, screening level hazard assessments or even risk assessment. More help

References

List of the literature that was cited for this AOP. More help

A. Alshawi and L. Agius. (2019), “Low metformin causes a more oxidized mitochondrial NADH/NAD redox state in hepatocytes and inhibits gluconeogenesis by a redox-independent mechanism,” The Journal of Biological Chemistry, Vol. 294/8, pp. 2839–2853, https://doi.org/10.1074/jbc.RA118.006670.

G. I. T. Cavalcante et al. (2017), “HIV antiretroviral drug Efavirenz induces anxiety-like and depression-like behavior in rats: evaluation of neurotransmitter alterations in the striatum,” European Journal of Pharmacology, Vol. 799, pp. 7–15, https://doi.org/10.1016/j.ejphar.2017.02.009.

L. Gao et al. (2022), “Fat mass and obesity-associated gene (FTO) hypermethylation induced by decabromodiphenyl ethane causing cardiac dysfunction via glucolipid metabolism disorder,” Ecotoxicology and Environmental Safety, Vol. 237, p. 113534, https://doi.org/10.1016/j.ecoenv.2022.113534.

J. J. Harris, R. Jolivet and D. Attwell. (2012), “Synaptic energy use and supply,” Neuron, Vol. 75/5, pp. 762–777, https://doi.org/10.1016/j.neuron.2012.08.019.

G. Hu et al. (2023), “Combined toxicity of acetamiprid and cadmium to larval zebrafish (Danio rerio) based on metabolomic analysis,” The Science of the Total Environment, Vol. 867, p. 161539, https://doi.org/10.1016/j.scitotenv.2023.161539.

J. Ji et al. (2022), “Multiview behavior and neurotransmitter analysis of zebrafish dyskinesia induced by 6PPD and its metabolites,” The Science of the Total Environment, Vol. 838/Pt 2, p. 156013, https://doi.org/10.1016/j.scitotenv.2022.156013.

G. Karamanlidis et al. (2013), “Mitochondrial Complex I Deficiency Increases Protein Acetylation and Accelerates Heart Failure,” Cell Metabolism, Vol. 18/2, pp. 239–250, https://doi.org/10.1016/j.cmet.2013.07.002.

M. Langer-Jaesrich et al. (2010), “Impairment of trophic interactions between zebrafish (Danio rerio) and midge larvae (Chironomus riparius) by chlorpyrifos,” Ecotoxicology, Vol. 19/7, pp. 1294–1301, https://doi.org/10.1007/s10646-010-0516-x.

Z. Lu et al. (2019), “Overexpression of BmFoxO inhibited larval growth and promoted glucose synthesis and lipolysis in silkworm,” Molecular genetics and genomics: MGG, Vol. 294/6, pp. 1375–1383, https://doi.org/10.1007/s00438-019-01550-2.

M. Parisotto et al. (2022), “The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer Cells,” Cancers, Vol. 14/22, p. 5597, https://doi.org/10.3390/cancers14225597.

Y. Sun et al. (2023), “Multi- and Transgenerational Developmental Impairments Are Induced by Decabromodiphenyl Ethane (DBDPE) in Zebrafish Larvae,” Environmental Science & Technology, Vol. 57/7, pp. 2887–2897, American Chemical Society, https://doi.org/10.1021/acs.est.3c00032.

D. V. Titov et al. (2016), “Complementation of mitochondrial electron transport chain by manipulation of the NAD+/NADH ratio,” Science, Vol. 352/6282, pp. 231–235, American Association for the Advancement of Science, https://doi.org/10.1126/science.aad4017.

R. Vartak, C. A.-M. Porras and Y. Bai. (2013), “Respiratory supercomplexes: structure, function and assembly,” Protein & Cell, Vol. 4/8, pp. 582–590, https://doi.org/10.1007/s13238-013-3032-y.

G. Vendemiale et al. (2001), “Mitochondrial oxidative injury and energy metabolism alteration in rat fatty liver: Effect of the nutritional status,” Hepatology, Vol. 33/4, pp. 808–815, https://doi.org/10.1053/jhep.2001.23060.

C. Wang et al. (2014), “Hepatic Overexpression of ATP Synthase β Subunit Activates PI3K/Akt Pathway to Ameliorate Hyperglycemia of Diabetic Mice,” Diabetes, Vol. 63/3, pp. 947–959, https://doi.org/10.2337/db13-1096.

A. Wu et al. (2021), “Developmental toxicity of procymidone to larval zebrafish based on physiological and transcriptomic analysis,” Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, Vol. 248, p. 109081, https://doi.org/10.1016/j.cbpc.2021.109081.

L. Yang et al. (2023), “Mitochondrial Dysfunction Was Involved in Decabromodiphenyl Ethane-Induced Glucolipid Metabolism Disorders and Neurotoxicity in Zebrafish Larvae,” Environmental Science & Technology, Vol. 57/30, pp. 11043–11055, American Chemical Society, https://doi.org/10.1021/acs.est.3c03552.

F. Yu et al. (2022), “Zinc alters behavioral phenotypes, neurotransmitter signatures, and immune homeostasis in male zebrafish (Danio rerio),” The Science of the Total Environment, Vol. 828, p. 154099, https://doi.org/10.1016/j.scitotenv.2022.154099.